These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16871815)

  • 21. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and development of a novel vaccine for protection against Lyme borreliosis.
    Comstedt P; Hanner M; Schüler W; Meinke A; Lundberg U
    PLoS One; 2014; 9(11):e113294. PubMed ID: 25409015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Lyme disease vaccines: past and future concerns.
    Nardelli DT; Munson EL; Callister SM; Schell RF
    Future Microbiol; 2009 May; 4(4):457-69. PubMed ID: 19416014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing the utilization of Lyme disease-prevention behaviors in a high-risk population.
    McKenna D; Faustini Y; Nowakowski J; Wormser GP
    J Am Acad Nurse Pract; 2004 Jan; 16(1):24-30. PubMed ID: 15008035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correcting a public health fiasco: The need for a new vaccine against Lyme disease.
    Plotkin SA
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s271-5. PubMed ID: 21217175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Academy of Pediatrics. Committee on Infecious Diseases. Prevention of Lyme disease.
    Pediatrics; 2000 Jan; 105(1 Pt 1):142-7. PubMed ID: 10617720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exposure and preventive behaviours toward ticks and Lyme disease in Canada: Results from a first national survey.
    Aenishaenslin C; Bouchard C; Koffi JK; Ogden NH
    Ticks Tick Borne Dis; 2017 Jan; 8(1):112-118. PubMed ID: 27771334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should speculations about immune-mediated adverse effects of Lyme disease vaccine deter us from giving it?
    Sigal L
    Cleve Clin J Med; 2000 Dec; 67(12):873-4. PubMed ID: 11127980
    [No Abstract]   [Full Text] [Related]  

  • 29. VLA15, a new global Lyme disease vaccine undergoes clinical trials.
    Hajdusek O; Perner J
    Lancet Infect Dis; 2023 Oct; 23(10):1105-1106. PubMed ID: 37419127
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccines against Lyme disease: What happened and what lessons can we learn?
    Poland GA
    Clin Infect Dis; 2011 Feb; 52 Suppl 3():s253-8. PubMed ID: 21217172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination against Lyme disease: Are we ready for it?
    Kaaijk P; Luytjes W
    Hum Vaccin Immunother; 2016 Mar; 12(3):757-62. PubMed ID: 26337648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for the use of Lyme disease vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1999 Jun; 48(RR-7):1-17, 21-5. PubMed ID: 10371254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old.
    Beran J; De Clercq N; Dieussaert I; Van Hoecke C
    Clin Infect Dis; 2000 Dec; 31(6):1504-7. PubMed ID: 11096024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program.
    Fowler GL; Baggs JM; Weintraub ES; Martin SW; McNeil MM; Gust DA
    Pharmacoepidemiol Drug Saf; 2006 Dec; 15(12):880-8. PubMed ID: 16924600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination perceptions of school employees in a rural school district.
    Macintosh J; Luthy KE; Beckstrand RL; Eden LM; Orton J
    Vaccine; 2014 Aug; 32(37):4766-71. PubMed ID: 25024111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What do we know about psychosocial risks at work? Part II.The analysis of employee's knowledge of sources and consequences of stress at work].
    Potocka A; Merecz-Kot D
    Med Pr; 2010; 61(4):393-411. PubMed ID: 20865853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Against Lyme borreliosis vaccination also, soon. Until then: antibiotics as early as possible!].
    Bischoff A
    MMW Fortschr Med; 2002 Feb; 144(9):4-6, 8. PubMed ID: 11921651
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Budd SM; Gibney KM
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of rapid changes in Lyme disease awareness in Canada.
    Aenishaenslin C; Bouchard C; Koffi JK; Pelcat Y; Ogden NH
    Ticks Tick Borne Dis; 2016 Oct; 7(6):1067-1074. PubMed ID: 27665265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.